Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year debt growth rate
Latest
124.38%
↓ 10% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
138.28%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 124.38% |
| Q3 2025 | 0.35% |
| Q2 2025 | 898.68% |
| Q1 2025 | -5.59% |
| Q4 2024 | -5.19% |
| Q3 2024 | -4.78% |
| Q2 2024 | 237.32% |
| Q1 2024 | -17.73% |
| Q4 2023 | -14.85% |
| Q3 2023 | -12.74% |
| Q2 2023 | -11.03% |
| Q1 2023 | -9.70% |
| Q4 2022 | -8.62% |
| Q3 2022 | -7.87% |
| Q2 2022 | -7.10% |
| Q1 2022 | -6.38% |
| Q4 2021 | -5.94% |
| Q3 2021 | -1.17% |
| Q2 2021 | -5.08% |
| Q1 2021 | -4.67% |
| Q4 2020 | -3.38% |
| Q3 2020 | -16.06% |
| Q2 2020 | 33.75% |
| Q1 2020 | -3.55% |
| Q4 2019 | -8.68% |
| Q3 2019 | -16.27% |
| Q2 2019 | -8.16% |
| Q1 2019 | 333.61% |
| Q4 2018 | -71.53% |
| Q3 2018 | 6.19% |
| Q2 2018 | 3712.11% |
| Q1 2018 | -92.35% |
| Q4 2017 | 1.52% |
| Q3 2017 | 3.17% |
| Q2 2017 | -85.72% |
| Q1 2017 | 768.82% |
| Q4 2016 | -54.49% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |